Detalles de la búsqueda
1.
Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set.
Semin Arthritis Rheum
; 60: 152191, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36963128
2.
Association between serum urate and flares in people with gout and evidence for surrogate status: a secondary analysis of two randomised controlled trials.
Lancet Rheumatol
; 4(1): e53-e60, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38288731
3.
Erratum to "Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis".
Semin Arthritis Rheum
; 63: 152255, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37598587
4.
Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis.
Semin Arthritis Rheum
; 48(2): 293-301, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29566967
5.
Variability in the Reporting of Serum Urate and Flares in Gout Clinical Trials: Need for Minimum Reporting Requirements.
J Rheumatol
; 45(3): 419-424, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29247147
6.
Using serum urate as a validated surrogate end point for flares in patients with gout: protocol for a systematic review and meta-regression analysis.
BMJ Open
; 6(9): e012026, 2016 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27650765
Resultados
1 -
6
de 6
1
Próxima >
>>